Physician profile
Robert E Brown
NPI 1487630059
$2,828.50
in general payments reported to CMS, 2019-2025
19 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $113 · 2021: $192 · 2022: $1,627 · 2023: $391 · 2024: $177 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $1,540.53 | 2022-2024 | Mild Device Kit |
| Boston Scientific Corporation | $423.62 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Spr Therapeutics, INC | $340.31 | 2022-2025 | Sprint Pns System |
| Pfizer INC. | $68.28 | 2020-2021 | |
| Vertiflex, INC. | $59.02 | 2019 | |
| Almatica Pharma LLC | $42.64 | 2021 | |
| Spinal Simplicity, LLC | $40.02 | 2023 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $36.19 | 2022-2023 | Xtampza |
| Nevro Corp. | $35.47 | 2019-2024 | Senza |
| Depuy Synthes Sales INC. | $35.08 | 2025 | Orthovisc, Monovisc |
| Scilex Pharmaceuticals INC. | $35.04 | 2021 | |
| Redhill Biopharma INC. | $33.16 | 2021-2022 | |
| Si-Bone, INC. | $30.46 | 2025 | |
| Painteq LLC | $27.52 | 2024 | Painteq |
| Arbor Pharmaceuticals, INC. | $19.72 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $17.39 | 2019 | |
| Biodelivery Sciences International, INC. | $15.24 | 2021 | |
| Bioventus LLC | $15.19 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.